Experimental Eye Research

Drug pair limited retinal nerve-cell loss in mice

In mice with or without surgically removed ovaries, two drugs limited retinal nerve-cell loss to 18% and restored retinal function to near-normal levels.

Paper by Piotr Rodak, Klaudia Mróz, Anna Pacwa, +5 more authorsAdrian Smędowski · Medical University of Silesia
Studied:
Experiments in 62 mice
What changed:
Combined treatment limited retinal ganglion cell loss to 18% in mice
The catch:
Mouse groups contained only four to six animals

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In an experiment involving 62 mice, researchers used ovary removal to model menopause, then tested retinal nerve cells after blood flow was interrupted and restored. Estrogen deficiency worsened nerve-cell loss by approximately 60% and severely impaired recovery of retinal function.

Raloxifene, a drug that alters estrogen receptor signaling, or KP7-6, which blocks a cell-death receptor called Fas, each provided partial protection. Together, they limited loss of nerve-cell bodies to 18% and restored retinal function to near-normal levels in mice both with and without ovaries. In 15 retinal tissue samples maintained outside the body, the combination increased neuronal survival twofold and reduced toxicity to cells. The authors suggested that jointly targeting estrogen-dependent survival signals and programmed cell death could offer a strategy for age-related neurodegenerative disorders.

Why it matters

Age-related estrogen decline raises questions about how hormonal changes affect nerve cells’ ability to withstand injury. This work examined the intersection of hormone signaling and programmed cell death as a potential target for neurodegeneration research.

Caveats

These experiments tested surgically induced menopause and retinal injury, not natural aging or benefits in people. The mouse groups contained four to six animals.

Comments

Be the first to comment.